Applications open for Australia’s first ‘deep technology’ AgTech commercialisation program

Australia’s only “super incubator”, Cicada Innovations, in partnership with MLA Donor Company (MDC), is calling for applicants to their Australian-first deep technology AgTech program for the Australian agriculture and food sectors.

The program, called GrowLab, is designed to help talented agricultural technologists capture a portion of the $100 billion Australian AgTech opportunity by guiding them through the process of commercialising their advanced AgTech innovations in areas such as robotics, animal health, remote sensing, food technologies and decision support tools.

Read more

Bayer Awards $2 Million in Grants to Advance Hemophilia Research and Patient Care

Bayer has awarded grants totaling more than $2 millionto 16 recipients across eight countries as part of its prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and researchers from the Children’s Hospital of Philadelphiaand Uniformed Services University of the Health Sciencesin Marylandare among the winners. Grant recipients were announced last night during a reception at the International Society on Thrombosis and Hemostasis (ISTH) 2017 Congress, Berlin, Germany.

Currently in its 15 year, BHAP is the largest program of its kind that recognizes and supports innovative research and educational initiatives to benefit the hemophilia community and exemplifies Bayer’s mission of ‘Science for a Better Life.’

Read more

There’s a new way to bet on the companies that bet on sports

Investors have a new opportunity to bet on the companies that sponsor the big four US sports leagues: the MLB, NHL, NFL, and NBA.

SportsETFs, a California-based firm, has launched its Pro Sports Sponsors ETF, which tracks the firm’s Pro Sports Sponsors Index. It began trading Tuesday morning under the ticker FANZ on Bats, the Kansas-based US stock exchange operator.

The logos of the 66 companies covered by the index, which include the likes of Pepsi, McDonald’s and Coca-Cola, are ubiquitous at American stadiums and arenas.

Read more

What are analysts saying about Hutchison China MediTech Limited’s (AIM:HCM) future?

With -173.9% predicted earnings drop over the next year Hutchison China MediTech Limited (AIM:HCM) doesn’t seem to be a very well performing company. What are the important facts you need to know? I will analyse the latest data and look at the future of this company in more detail.

Troubled times ahead?
The bad news for investors in HCM is that a drop in earnings is on the cards. Analysts covering the company are expecting the EPS to drop down to $0.18, a significant decline from previous levels of around $0.2. Based on the estimates this means a -16.5% reduction in three year’s time. Not the best news.

Read more

The tiny discovery with big biosecurity benefits

Plant Biosecurity CRC researchers based at Agriculture Victoria’s AgriBio, Centre for AgriBiosciences, have discovered a new bacterium, a novel candidate species of Liberibacter, inside a native Australian eggplant psyllid, Acizzia solanicola. Its discovery can help ensure diagnostic tests do not give false results for destructive diseases associated with other types of psyllids. The benefits for industry are potentially significant, as false results can be highly damaging for trade.

Psyllids are tiny insects that can spread bacteria that cause devastating plant diseases, such as zebra chip disease in potatoes and citrus greening – diseases that are not yet present in Australia.

Read more

Novel approach could offer hope in treatment of inflammatory conditions

The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune diseases, and sepsis.

In a study published this week in the journal Nature Communications, they explain how blocking a single enzyme-enabled them to reprogram macrophages – the immune cells which are activated in inflammatory conditions – to calm their activity and reduce inflammation in rats and mice with human-like disease.

Read more

Applications open for AgTech commercialisation program

Australia’s only “super incubator”, Cicada Innovations, in partnership with MLA Donor Company (MDC), is calling for applicants to their Australian-first deep technology AgTech program for the Australian agriculture and food sectors.

The program, called GrowLab, is designed to help talented agricultural technologists capture a portion of the $100 billion Australian AgTech opportunity by guiding them through the process of commercialising their advanced AgTech innovations in areas such as robotics, animal health, remote sensing, food technologies and decision support tools.

Read more

Noticeable Price Move: Protalix BioTherapeutics, Inc. (PLX)

In Healthcare sector, shares of Protalix BioTherapeutics, Inc. (PLX) were valued at $0.77 and moved -3.76% as of a recent closing trade. A total volume of 0.4 million shares were traded versus to average volume of 1.43 million shares. Protalix BioTherapeutics, Inc. (PLX) shares have been seen trading -49.49% off its 52 week- peak value and changed 194.27% from its 52 week-bottom price value. The “percentage off the 52-week high or low” refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.

In terms of Protalix BioTherapeutics, Inc. (PLX) stock price comparison to its moving averages, shares of company are -10.89% away from the 50-day moving average and -6.51% away from 20-day average. If we take a long term observation, shares have been trading at a distance of 1.32% from the 200-day moving average. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also facilitate in determining where it may be possibly heading.

Read more

The pros and cons of heating your home with a fireplace

The pros and cons of heating your home with a fireplace

Choosing a heating type might be one of the most important decisions you make for your home. Not only could you end up saving money upfront and in the future, the right type of heater can make your family healthier and improve your quality of life.

It pays to do your research before choosing what type of heating to install in your home, so we’ve rounded up some of the main pros and cons to get you started. But first…

Read more